(Q53674063)

17 May 2018

title

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers. (English)

1 reference

17 May 2018

1 reference

1 reference

Yukie Enomoto

1

1 reference

17 May 2018

Takashi Morimoto

2

1 reference

17 May 2018

Arisa Nishimukai

3

1 reference

17 May 2018

Tomoko Higuchi

4

1 reference

17 May 2018

Ayako Yanai

5

1 reference

17 May 2018

Yoshimasa Miyagawa

6

1 reference

17 May 2018

Keiko Murase

7

1 reference

17 May 2018

Michiko Imamura

8

1 reference

17 May 2018

Yuichi Takatsuka

9

1 reference

17 May 2018

Takashi Nomura

10

1 reference

17 May 2018

Masashi Takeda

11

1 reference

17 May 2018

Takahiro Watanabe

12

1 reference

17 May 2018

Seiichi Hirota

13

1 reference

17 May 2018

Yasuo Miyoshi

14

1 reference

17 May 2018

publication date

4 September 2015

1 reference

17 May 2018

International Journal of Clinical Oncology

published in

1 reference

17 May 2018

volume

21

1 reference

17 May 2018

issue

2

1 reference

17 May 2018

page(s)

254-261

1 reference

17 May 2018

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Response-guided neoadjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Tumor response ratio predicts overall survival in breast cancer patients treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-bas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-015-0897-1

EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

21 January 2018

1 reference

12 December 2020

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study

1 reference

12 December 2020

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

1 reference

12 December 2020

The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis

1 reference

12 December 2020

Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?

1 reference

12 December 2020

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

1 reference

12 December 2020

10.1007/S10147-015-0897-1

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018